Nvidia RTX 4080 GPU could get cheaper with a new version – but don’t get your hopes up

An Nvidia GeForce RTX 4080 on a wooden desk in front of a white panel



(Image credit: Future)

Nvidia’s RTX 4080 is purportedly getting a new spin on the GPU which could reduce the cost – but any price reduction will likely be very minor, sadly, if it happens at all.

Tom’s Hardware (opens in new tab) flagged up this rumor – and treat it with caution, as with anything from the ever-spinning mill – that originated from HKEPC (opens in new tab) (a tech site in Hong Kong), claiming that while the current RTX 4080 graphics card is built on the AD103-300 chip, Nvidia is going to use a slightly different GPU in the future, namely AD103-301.

There’s now more evidence this is actually happening, Tom’s points out: graphics card maker Galax has the GPU as ‘AD103-300/301’ under its RTX 4080 product details lists.

Furthermore, VideoCardz (opens in new tab), which also picked up on this, informs us that another card maker Gainward has also listed the updated GPU variant AD103-301 in its product specs.

With two separate third-party graphics card makers mentioning this new spin on the GPU in their specs, it seems pretty likely this is actually happening – but of course it remains to be confirmed by Nvidia.

HKEPC makes a further claim that the inbound RTX 4070 (the vanilla version of the RTX 4070 Ti, which has just been unveiled) might also take the approach of having two different chips, which in this case would theoretically be AD104-250 and AD104-251. The difference is the former supposedly uses a comparator circuit, but the latter doesn’t, and would use a different circuit board, potentially lowering the cost of making the card.

The same is true of the RTX 4080 and new AD103-301, with it potentially lowering the cost of building it (the BOM or bill of materials as it’s known in the industry). The key question is, if all this pans out for both or either GPUs, how much cheaper might the second variants actually be?


Analysis: Will this mean cheaper graphics cards – or is that a false hope?

HKEPC reckons that the cost gap between the supposed different versions of the RTX 4070 could be as little as $1 in terms of the bill of materials, which is clearly a tiny amount, and likely wouldn’t make a jot of difference to the price that the consumer pays. A source that VideoCardz tapped also claims that any cost difference wouldn’t be significant.

We aren’t given any figure for the potential difference in the cost of making the RTX 4080 versions, but the new AD103-301 might lower the bill to a greater extent, and perhaps mean the graphics card does get cheaper for the consumer. However, it might be a similarly very minor reduction in the BOM, which would doubtless do little to affect the price of the second spin on the RTX 4080.

Time will tell, but given Nvidia’s stance on pricing with Lovelace GPUs overall, it’s hard to be at all optimistic.

Another question is given the change to the RTX 4080 chip, would this affect performance? The rumor mill is pretty clear in its assertion that it wouldn’t, and the AD103-301 chip will not be any more performant than the existing AD103-300. That makes sense, as Nvidia would presumably be wary of dropping a dose of buyer’s remorse on those who’ve already forked out for an RTX 4080, and splashed a large wedge of cash to do so.

The overall upshot of this is likely to be graphics cards with the same performance level – or so similar as to be negligible – and slight savings for the board makers, that likely won’t be passed on to consumers. Hopefully a more favorable situation could pan out, though, cost-wise, so keep your fingers crossed if you’re in the market for a high-end GPU.

Sign up to get breaking news, reviews, opinion, analysis and more, plus the hottest tech deals!

Darren is a freelancer writing news and features for TechRadar (and occasionally T3) across a broad range of computing topics including CPUs, GPUs, various other hardware, VPNs, antivirus and more. He has written about tech for the best part of three decades, and writes books in his spare time (his debut novel – ‘I Know What You Did Last Supper’ – was published by Hachette UK in 2013).

Read More
Joan Howe

Latest

Festering Infections to Untreated Cancer: ICE Detainees Describe Medical Neglect Across US

An Albanian man’s pain grew so unbearable, he said, he pulled out his own tooth as he languished for months in a New Mexico immigration detention center. A Honduran mother of two said she was hospitalized for a heart problem after she was denied blood pressure medications while held in Florida. A Venezuelan man said

Focused on Work, Needed at Home: A Federal Caregiving Policy Might Help

(Candice Evers for WPLN and KFF Health News) Jill Woodrow reached a tipping point as a caregiver when her mom began struggling to communicate information about her latest doctor appointments. Woodrow’s mother, a uterine cancer survivor, was seeing specialists to get to the bottom of several new, concerning symptoms. “When she would try to tell

How digital platforms and policy shifts reshape GLP-1 affordability

🛡️ Just a quick check We’re checking your connection to prevent automated abuse

Baffling. Frustrating. Frightening. What It’s Like To Be Sued Over Medical Debt.

When Christine Wood received a $12,000 bill from Bristol Hospital, she thought it must be a mistake. It was more than she and her husband made in a month combined. “I’m freaking out,” said Wood, who lives in a 1,700-square-foot home in Terryville, a village just outside Bristol, Connecticut. “I don’t understand it.” Wood, 52

Newsletter

Don't miss

Festering Infections to Untreated Cancer: ICE Detainees Describe Medical Neglect Across US

An Albanian man’s pain grew so unbearable, he said, he pulled out his own tooth as he languished for months in a New Mexico immigration detention center. A Honduran mother of two said she was hospitalized for a heart problem after she was denied blood pressure medications while held in Florida. A Venezuelan man said

Focused on Work, Needed at Home: A Federal Caregiving Policy Might Help

(Candice Evers for WPLN and KFF Health News) Jill Woodrow reached a tipping point as a caregiver when her mom began struggling to communicate information about her latest doctor appointments. Woodrow’s mother, a uterine cancer survivor, was seeing specialists to get to the bottom of several new, concerning symptoms. “When she would try to tell

How digital platforms and policy shifts reshape GLP-1 affordability

🛡️ Just a quick check We’re checking your connection to prevent automated abuse

Baffling. Frustrating. Frightening. What It’s Like To Be Sued Over Medical Debt.

When Christine Wood received a $12,000 bill from Bristol Hospital, she thought it must be a mistake. It was more than she and her husband made in a month combined. “I’m freaking out,” said Wood, who lives in a 1,700-square-foot home in Terryville, a village just outside Bristol, Connecticut. “I don’t understand it.” Wood, 52

Former Angels Top Prospect Jordyn Adams, 26, Commits To SMU Football

The 2018 wide receiver recruiting class was spearheaded by top prospects Amon-Ra St. Brown and Ja’Marr Chase. Both elite talents lived up to the immense hype and have since become All-Pro receivers in the NFL. Lost in that group was the player who sat between Brown and Chase in the rankings — a once highly-touted

Jury acquits 2 business executives of bribing Navy admiral for government contract

A federal jury has acquitted two business executives of charges that they conspired to bribe a retired four-star U.S. Navy admiral, who is now serving a six-year prison sentence for his conviction on corruption charges By MICHAEL KUNZELMAN Associated Press WASHINGTON -- A federal jury has acquitted two business executives of charges that they conspired

US Business Leaders Optimistic About China Cooperation, Emphasize Importance of Chinese Market

© 2026 China Money Network. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.

Tesla’s Business Has Become Much More Diversified in Just the Past Five Years. Does That Make Its Stock a Better Buy Today?

Key Points Tesla's energy generation and storage segment generated 27% revenue growth last year. The company's non-automotive segments were able to help offset a double-digit decline in auto revenue in 2025. These 10 stocks could mint the next wave of millionaires › Tesla (NASDAQ: TSLA) is known for its electric vehicles (EVs), and while they